European Investment Bank

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026

The European Investment Bank, abbreviated EIB, is the bank named in Reactive Technologies and Tensive financing announcements.

Recorded funding activity

Reactive measures electricity-grid inertia and stability in real time. Other recorded activity includes Morphotonics’ optical-component manufacturing equipment and HighLife’s transcatheter heart-valve technology. The bank remains distinct from the European Investment Fund and other institutions.

Sources
Rounds participated in
6
Confirmed lead rounds
0
1 roles undisclosed
New companies
6
First participation on record · 0 follow-on
Funding in participating rounds
$146.1M
3 disclosed · full round size, not this investor’s share

By stage

Undisclosed4
Growth1
Series C+1

By primary sector

Healthtech6

By country

Italy3
Finland1
France1
Sweden1

Rounds

6 in this selection
HighLife

HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.

€80MFinancing round
Participant
MMI

Medical Microinstruments (MMI) makes the Symani robotic microsurgery system for surgeons treating patients who need reconstructive microsurgery or supermicrosurgery. Its wristed instruments scale and steady surgeons’ hand movements for precise work on very small blood vessels and soft tissue.

€17M€17 million co-investment
Participant
Tensive

Clinical-stage bioresorbable implants designed to support natural breast-tissue regeneration and mark the tumour bed after lumpectomy.

≤€20MConvertible venture debt
Participant
Elekta

Elekta makes radiation-treatment systems and oncology software for clinical teams treating cancer and selected neurological conditions.

≤€100MEIB loan
Participant
Aiforia

Aiforia builds AI software that helps pathologists analyse digital images of tissue samples.

≤€20MVenture debt facility
Participant
WISE

Develops advanced implantable electrodes for neuromonitoring, neuromodulation, and brain-computer interfaces

€30MSeries D
Role not disclosed